Fmoc-MRWQEMGYIFYPRKLR-OH

Ref. 3D-PP45096

Informations sur le produit

• Nom: Fmoc-MRWQEMGYIFYPRKLR-OH
• Synonymes: Fmoc-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH

Description

Peptide Fmoc-MRWQEMGYIFYPRKLR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Fmoc-MRWQEMGYIFYPRKLR-OH include the following: MOTS-c, the most recent mitochondrial derived peptide in human aging and age-related diseases Z Mohtashami , MK Singh, N Salimiaghdam - International journal of , 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/19/11991 Bioenergetic Metabolism Modulatory Peptide Hydrogel for Cardiac Protection and Repair After Myocardial Infarction Y Zhang, Y Gao, J Wang, R Gao, Q Su - Advanced Functional , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adfm.202312772 MOTS-c promotes muscle differentiation in vitro S Garcaca­a-Benlloch, F Revert-Ros, JR Blesa, R Alis - Peptides, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978122001061 Orally administered MOTS-c analogue ameliorates dextran sulfate sodium-induced colitis by inhibiting inflammation and apoptosis JH Jiang, X Chang, YY Nie, L Xu, L Yang - European Journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014299922007300 The mitochondrial genome-encoded peptide MOTS-c interacts with Bcl-2 to alleviate nonalcoholic steatohepatitis progression H Lu, L Fan, W Zhang, G Chen, A Xiang, L Wang, Z Lu - Cell Reports, 2024 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(23)01599-1.pdf MOTS-c 加区ڮ°å¿†å¹¶é€šÚ¿‡ AMPK ÊŠ‘åˆ¶ç¥şç»ç‚Ŝ症减猓ڮ°å¿†ÊŞÀŒ€ 姜锊红 - 2019 - ir.lzu.edu.cnhttps://ir.lzu.edu.cn/handle/262010/341906

• Marque: Biosynth